APA (7th ed.) Citation

SL, S., BB, R., AF, L., S, R., I, F., KL, J., . . . RM, A. (2024). An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. The Journal of clinical investigation, 134(4), . https://doi.org/10.1172/JCI172980

Chicago Style (17th ed.) Citation

SL, Sneed, Reese BB, Laureano AF, Ratnapriya S, Fraschilla I, Jeffrey KL, Coffey GP, Conley PB, and Anthony RM. "An Engineered Immunomodulatory IgG1 Fc Suppresses Autoimmune Inflammation Through Pathways Shared with I.v. Immunoglobulin." The Journal of Clinical Investigation 134, no. 4 (2024). https://doi.org/10.1172/JCI172980.

MLA (9th ed.) Citation

SL, Sneed, et al. "An Engineered Immunomodulatory IgG1 Fc Suppresses Autoimmune Inflammation Through Pathways Shared with I.v. Immunoglobulin." The Journal of Clinical Investigation, vol. 134, no. 4, 2024, https://doi.org/10.1172/JCI172980.